Trials / Recruiting
RecruitingNCT07243639
Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
A Prospective Study on the Efficacy and Safety of a Novel Oral Drug, Etrasimod, in Elderly Patients With Ulcerative Colitis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Showa Inan General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etrasimod administration | 2 mg of Etrasimod is orally administered everyday. |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2025-11-24
- Last updated
- 2025-12-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT07243639. Inclusion in this directory is not an endorsement.